Full text

Turn on search term navigation

This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

In the article titled “Prevalence of Fracture Risk Factors in Postmenopausal Women Enrolled in the POSSIBLE US Treatment Cohort” [1], there was an error regarding the FRAX® tool, which should be clarified as follows:

The article notes “The WHO fracture risk assessment tool (FRAX) is a computer-based algorithm that assesses fracture probability of men and women [1].” However, the World Health Organization (WHO) did not develop, test, or endorse the FRAX tool or its recommendations [2]. The metabolic bone disease unit at the University of Sheffield that developed FRAX was a WHO Collaborating Centre from 1991 to 2010, but treatment guidelines must undergo a formal process before they can be endorsed by the WHO.

References

[1] N. Yurgin, S. Wade, S. Satram-Hoang, D. Macarios, M. Hochberg, "Prevalence of fracture risk factors in postmenopausal women enrolled in the POSSIBLE US treatment cohort," International Journal of Endocrinology, vol. 2013,DOI: 10.1155/2013/715025, 2013.

[2] N. Ford, S. L. Norris, S. R. Hill, "Clarifying WHO’s position on the FRAX® tool for fracture prediction," Bulletin of the World Health Organization, vol. 94 no. 12,DOI: 10.2471/BLT.16.188532, 2016.

Word count: 205

Show less

Copyright © 2017 Nicole Yurgin et al. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Details

Title
Corrigendum to “Prevalence of Fracture Risk Factors in Postmenopausal Women Enrolled in the POSSIBLE US Treatment Cohort”
Author
Yurgin, Nicole 1 ; Wade, Sally 2 ; Satram-Hoang, Sacha 3   VIAFID ORCID Logo  ; Macarios, David 1 ; Hochberg, Marc 4 

1  Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320-1799, USA 
2  Wade Outcomes Research and Consulting, 358 South 700 East, Suite B432, Salt Lake City, UT 84102, USA 
3  Q.D. Research, Inc., 8789 Auburn Folsom Road, Suite C501, Granite Bay, CA 95746, USA 
4  Division of Rheumatology and Clinical Immunology, University of Maryland School of Medicine, 10 S. Pine Street, MSTF 8-34, Baltimore, MD 21201, USA 
Publication year
2017
Publication date
2017
Publisher
John Wiley & Sons, Inc.
Source type
Scholarly Journal
Language of publication
English
DOI
https://doi.org/10.1155/2017/4827469
ProQuest document ID
2410480847
Copyright
Copyright © 2017 Nicole Yurgin et al. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.